Market Research Report
U.S. Fertility Clinics & Infertility Services: An Industry Analysis
|Published by||Marketdata LLC||Product code||96327|
|Published||Content info||132 Pages; 34 Tables
Delivery time: 1-2 business days
|U.S. Fertility Clinics & Infertility Services: An Industry Analysis|
|Published: November 28, 2018||Content info: 132 Pages; 34 Tables||
This analysis by Marketdata examines the controversial $5.8 billion infertility services/fertility clinics growth industry. This loosely regulated “baby business” has weathered the last recession pretty well and has grown strongly since 2014, boosted both by demand domestically and via medical tourism patients from Europe and China. This largely untapped market is characterized by favorable demographics and a strong economy. Venture capital firms are eyeing the potential.
ART (assisted reproductive technology) now produces more than 50,000 babies per year in the U.S. via 263,000 IVF procedures, and demand is growing from the ranks of 7+ million infertile women, many of which delayed childbearing due to careers. Foreigners and gay couples are two other areas of growth. There are about 480 U.S. fertility clinics, 100+ sperm banks, an unknown number of egg donors, and 1,700 reproductive endocrinologists competing for the business, which is lucrative. In addition, the global market for fertility drugs is just under $1 billion. Only one large “chain”, IntegraMed, exists, as most programs are run by small MD practices or are part of a hospital or University. The market is fragmented, served by mostly small regional clinics.
This 3rd edition study by Marketdata examines the nature/evolution of the business, national receipts/growth from 1988 to 2023 forecast, infertile customer demographics, key industry trends, industry regulation, pricing, industry consolidation, insurance coverage, ethical issues, and more. Contains results of the latest (2015-2016) CDC ART survey national data, with IVF success rates and long-term trends, as well as European ART cycles survey data. The report also examines the nature/size of the U.S. sperm banks, egg donors, and fertility drugs markets, and surrogacy programs.
Competitor Profiles for: Cryos International, California Cryobank, Resolve, Allan Guttmacher Institute, Genetics and IVF Institute, IntegraMed America.
This study is believed to be one of the few in-depth publicly available business analyses that exists of this market. It's ALL here in one place.